About
Technology
Issues
FAQ
Links
Official Page
A phase II study of atezolizumab (atezo) with or without bevacizumab (bev) versus sunitinib (sun) in untreated metastatic renal cell carcinoma (mRCC) patients (pts).
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.